Ann: Response to TMT Analytics Report, page-77

Every LTH needs keep a hard copy of

1. TMTA coverage , esp p 1-4, 15-27

Share price target = 94c

In 12 months, based on f/c revenues:
Y1 = $16.5m,
Y2 = $46.5m
Y3 = $75.0m
etc


2. RV's spreadsheet on binding MOUs, up to 09/11/17
Post #: 28543842


Then

3. Study Taiwan/India deal
10/11/17,
Binding MOU for Distribution in India and Taiwan

Y1 = U$90m = A$120m (0.8m units @A$150)
Y2 = U$135m = A175m
Y3 = U$180m = A$230m




4. Compare with my simple & conservative valuation,
$1.85-$2.20

post #: 32482603
conditional on imminent CFDA approval & factory opening & Taiwan/India Letter of Credit & telcos arrangement sorted.


WHY?
So when trolls & cappers with deep-pockets come to do the things they have been doing for last 6-10 months, you can stand strong. Why? You are part-owner of one of the most undervalued companies/stocks in asx.

Gmed will prevail and prosper.
Thanks to Dr Yacov !
Gltah.


Cheers
Aimo
G

~